Each day at SYNLAB, our scientists around the world are researching, publishing and collaborating with partners in scientific excellence. This work lays pivotal groundwork for advancement in disease prevention, diagnostics and decision support, treatment and patient quality of life.
Each year, we recognise this commitment with our very own Medical Innovation Awards. Driven by customer needs, our 2023 awardees have contributed to medical excellence in the fields of:
Turning scientific research into innovative services and products starts with the compound of an idea and the willingness to think it further, refine and transform it. This page introduces you to our award recipients, their publications and inspirations.
SYNLAB Portugal
Comprehensive genomic profiling of cell-free circulating tumor DNA detects response to ribociclib plus letrozole in a patient with metastatic breast cancer
National Library of Medicine – pubmed.ncbi.nlm.nih.gov/36551247/
SYNLAB Spain
Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/36163066/
SYNLAB UK | Synnovis
Exclusively breastmilk-fed preterm infants are at high risk of developing subclinical vitamin K deficiency despite intramuscular prophylaxis at birth
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/36087073/
SYNLAB Italy
A pathomic approach for tumor-infiltrating lymphocytes classification on breast cancer digital pathology images
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/36950640/
SYNLAB Italy
Bringing cumulative technological culture beyond copying versus reasoning
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/36283920/
SYNLAB Italy
A framework of analysis to facilitate the harmonization of multicenter radiomic features in prostate cancer
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/36614941/
SYNLAB UK & Ireland
Operation Moonshot: rapid translation of a SARS-CoV-2 targeted peptide immunoaffinity liquid chromatography-tandem mass spectrometry test from research into routine clinical use
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/36395058/
SYNLAB Germany
Two-stage tuberculosis diagnostics: combining centrifugal microfluidics to detect TB infection and Inh and Rif resistance at the point of care with subsequent antibiotic resistance profiling by targeted NGS
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/37999937/
The spread of SARS-CoV-2 has become a serious challenge for public health, economy and social life in Europe and other regions of the world. To flatten the curve of new infections, not only social distancing and restrictions in public life but also fast and reliable testing plays an essential role.
SYNLAB is the leader in medical diagnostic services and specialty testing in Europe. Our mission is to provide advanced services in every diagnostic category for the benefit of you and your health. State-of-the-art technology, novel testing capabilities and an international network of medical professionals means we can offer a catalogue of more than 5000 routine and specialised tests. Fast, safe, reliable and always close by. We would like to welcome you to our world.
Forging links between medical disciplines and leading international specialists: because your success means a lot to us. Backed by SYNLAB’s team of international experts in more than 30 countries worldwide, we deliver diagnostic services of the highest calibre and make a significant contribution to interdisciplinary research.
Our expert teams and state-of-the-art diagnostic services are present in more than 30 countries on four continents. Get an insight into the history of our company and find out what drives us.
Find our job offers at our country pages and start your career with SYNLAB, the leader in medical diagnostic services and specialty testing in Europe.